Menu

Resources

Publication

Poster

Publication

Video Poster

Webinar

18 June 2021
Health and longevity studies in C. elegans: the ‘‘healthy worm database’’ reveals strengths, weaknesses and gaps of test compound-based studies.

An overview of the use of C. elegans in longevity research including the genetic manipulation of animals.

Read More
21 June 2021
C. elegans Automated Imaging in Drug Discovery

De-risking drug candidates ahead of rodent studies with a non-mammalian model for ageing, neurodegeneration and the microbiome using C. elegans.

Read More
21 June 2021
C. elegans Automated Imaging Platform

Magnitude Biosciences presentation from ELRIG online 2020 on the use of C. elegans in pre- clinical drug trials for ageing, neurodegeneration and microbiome.

Read More
21 June 2021
Automated Imaging of C. elegans for Ageing, Neurodegeneration and Behaviour

How large scale non-invasive imaging of C. elegans to enable reliable measurement of Ageing, Neurodegeneration and Behaviour.

Read More
21 June 2021
Microbiome SIG Webinar Series

Our CEO, Dr. David Weinkove, explains how healthspan readouts can be used to understand mechanisms in the microbiome.

Read More
21 June 2021
UK SPINE Recording

Our CEO, David Weinkove, discusses the use of C. elegans and how they could be used in the field of Geroscience to accelerate the drug development process.

Read More
21 June 2021
Chemosensory Neurons Modulate the Response to Oomycete Recognition in Caenorhabditis elegans

The Barkoulas Lab, including our own Michael Fasseas , find an Oomycetes recognition response in C. elegans which leads to a reduction in the attachment of pathogens with applications for immunity and animal survival.

Read More
21 June 2021
Neuronal SKN-1B modulates nutritional signalling pathways and mitochondrial networks to control satiety

Neuronal SKN-1B modulates nutritional signalling pathways and mitochondrial networks to control satiety

Read More
21 June 2021
C. elegans mobility decline

This video shows an automated method to quantify that decline developed by Magnitude Bioscienceswhich can be used to evaluate and develop therapies that delay ageing or degenerative disease.

Read More
C. elegans to accelerate industrial drug discovery and address the costs and challenges of early preclinical research
Magnitude Bioscience CEO, David Weinkove, discusses the application of C. elegans to accelerate the industrial drug discovery process ...Read More
Developing a System to Quantify Efficacy of Neurodegeneration Therapeutics Using Automated Monitoring of C. elegans
Check out our poster showing how we can quantify the efficacy of neurodegeneration models...Read More
C. elegans mobility decline
This video shows an automated method to quantify that decline developed by Magnitude Biosciences which can be used to evaluate and develop therapies that delay ageing or degenerative disease...Read More
Neuronal SKN-1B modulates nutritional signalling pathways and mitochondrial networks to control satiety
Neuronal SKN-1B modulates nutritional signalling pathways and mitochondrial networks to control satiety...Read More
Chemosensory Neurons Modulate the Response to Oomycete Recognition in Caenorhabditis elegans
The Barkoulas Lab, including our own Michael Fasseas , find an Oomycetes recognition response in C. elegans which leads to a reduction in the attachment of pathogens with applications for immunity and animal survival....Read More
UK SPINE Recording
Our CEO, David Weinkove, discusses the use of C. elegans and how they could be used in the field of Geroscience to accelerate the drug development process....Read More
Microbiome SIG Webinar Series
Our CEO, Dr. David Weinkove, explains how healthspan readouts can be used to understand mechanisms in the microbiome....Read More
Automated Imaging of C. elegans for Ageing, Neurodegeneration and Behaviour
How large scale non-invasive imaging of C. elegans to enable reliable measurement of Ageing, Neurodegeneration and Behaviour....Read More
C. elegans Automated Imaging Platform
Magnitude Biosciences presentation from ELRIG online 2020 on the use of C. elegans in pre- clinical drug trials for ageing, neurodegeneration and microbiome....Read More

CONTACT US

Get in touch today to find out how we can 
support you to accelerate your research

CONTACT US

Get in touch today to find out how we can 
support you to accelerate your research
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram